Filing Details
- Accession Number:
- 0001209191-20-051736
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-23 20:00:19
- Reporting Period:
- 2020-09-23
- Accepted Time:
- 2020-09-23 20:00:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1438533 | Retrophin Inc. | RTRX | Pharmaceutical Preparations (2834) | 262383102 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1698262 | E. William Rote | C/O Retrophin, Inc. 3721 Valley Centre Drive, Ste 200 San Diego CA 92130 | Senior Vice President, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-09-23 | 1,500 | $18.48 | 24,086 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligationthat occurred upon the vesting of performance restricted stock units.